UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Efficacy and safety of glecaprevir/pibrentasvir in renally-impaired patients with chronic hepatitis C virus genotype 1–6 infection

JOURNAL OF HEPATOLOGY, 2018, Vol.68, p.S292

2018

Volltextzugriff (PDF)

Late-onset neutropaenia in ANCA-associated vasculitis after rituximab treatment

SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2014, Vol.43 (S127), p.50

2014

Volltextzugriff (PDF)

LONG-TERM KIDNEY FUNCTION OUTCOME AFTER COVID-19 ASSOCIATED ACUTE KIDNEY INJURY AND KIDNEY REPLACEMENT THERAPY IN INTENSIVE CARE

NEPHROLOGY DIALYSIS TRANSPLANTATION, 2022, Vol.37, p.I228

2022

Volltextzugriff (PDF)

Change in Albuminuria in Patients with ANCA-Associated Vasculitis Treated with Avacopan

ARTHRITIS & RHEUMATOLOGY, 2023, Vol.75, p.1719

2023

Volltextzugriff (PDF)

CHANGE IN ALBUMINURIA IN PATIENTS WITH ANCA-ASSOCIATED VASCULITIS TREATED WITH AVACOPAN

NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, Vol.38, p.I296

2023

Volltextzugriff (PDF)

Remission, Glucocorticoid Toxicity, Health-Related Quality of Life, and Safety Outcomes in Patients with Renal Involvement in the Phase 3 Trial of Avacopan for the Treatment of ANCA-Associated Vasculitis

ARTHRITIS & RHEUMATOLOGY, 2023, Vol.75, p.1363

2023

Volltextzugriff (PDF)

INCIDENT ACUTE KIDNEY INJURY AND THE RISK OF DEMENTIA: THE STOCKHOLM CREATININE MEASUREMENTS (SCREAM) PROJECT

NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, Vol.38, p.I99

2023

Volltextzugriff (PDF)

MYELOPEROXIDASE (MPO) POSITIVE EXTRACELLULAR VESICLES (EVS) EXPRESSING COMPLEMENT SPLIT PRODUCTS IN ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY (ANCA)-ASSOCIATED VASCULITIS (AAV)

ANNALS OF THE RHEUMATIC DISEASES, 2022, Vol.81, p.1434

2022

Volltextzugriff (PDF)

Renal Recovery for Patients With Baseline eGFR ≤20 in Avacopan ADVOCATE Trial

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, Vol.33 (11), p.501

2022

Volltextzugriff (PDF)

URINARY INTERLEUKIN (IL)-16 IN ANTI - NEUTROPHIL CYTOPLASMIC ANTIBODY (ANCA)- ASSOCIATED VASCULITIS WITH KIDNEY INVOLVEMENT

ANNALS OF THE RHEUMATIC DISEASES, 2023, Vol.82, p.1596

2023

Volltextzugriff (PDF)

Acceleration in kidney function decline after COVID-19 infection: the Stockholm CREAtinine Measurements (SCREAM) project

NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, Vol.39, p.I82

2024

Volltextzugriff (PDF)

Rituximab in adult-onset IgA vasculitis

NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, Vol.39, p.I238

2024

Volltextzugriff (PDF)

OUTCOME FOLLOWING COVID-19 INFECTION IN ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY (ANCA)-ASSOCIATED VASCULITIS

ANNALS OF THE RHEUMATIC DISEASES, 2021, Vol.80, p.898

2021

Volltextzugriff (PDF)

RNA SEQUENCING OF MICRODISSECTED KIDNEY BIOPSIES FROM IGA NEPHROPATHY PATIENTS

NEPHROLOGY DIALYSIS TRANSPLANTATION, 2022, Vol.37, p.I813

2022

Volltextzugriff (PDF)

COMPLEMENT FACTOR BB AND FACTOR C4D IN IGA NEPHROPATHY AND IGA VASCULITIS

NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, Vol.35, p.651

2020

Volltextzugriff (PDF)

First exposure to rituximab is associated to high rate of anti-drug antibodies in systemic lupus erythematosus but not in ANCA-associated vasculitis

EUROPEAN JOURNAL OF IMMUNOLOGY, 2021, Vol.51, p.386

2021

Volltextzugriff (PDF)

Effect of Avacopan, a Selective C5a Receptor Inhibitor, on Kidney Function in Patients with ANCA-Associated Vasculitis

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, Vol.32 (10), p.B1

2021

Volltextzugriff (PDF)

CHOLINESTERASE INHIBITORS AND KIDNEY FUNCTION DECLINE IN PATIENTS WITH ALZHEIMER'S DEMENTIA

NEPHROLOGY DIALYSIS TRANSPLANTATION, 2022, Vol.37, p.I847

2022

Volltextzugriff (PDF)

ANALYSIS OF THE PLASMA PROTEOME PROVIDES MECHANISTIC INSIGHTS INTO THE PATHOPHYSIOLOGY OF ANCA-ASSOCIATED VASCULITIS

ANNALS OF THE RHEUMATIC DISEASES, 2023, Vol.82, p.1073

2023

Volltextzugriff (PDF)

PENTRAXIN-3 PLASMA LEVELS AND GENE POLYMORPHISMS IN ANCA-ASSOCIATED VASCULITIS

RHEUMATOLOGY, 2019, Vol.58

2019

Volltextzugriff (PDF)

Proteinase 3 reactive CD4+T cells and their TCR repertoire in ANCA associated vasculitis

SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2021, Vol.94 (6)

2021

Volltextzugriff (PDF)

ACUTE KIDNEY INJURY AND MORTALITY RISK IN OLDER ADULTS WITH AND WITHOUT COVID-19: DATA FROM GEROCOVID STUDY

NEPHROLOGY DIALYSIS TRANSPLANTATION, 2021, Vol.36

2021

Volltextzugriff (PDF)

AUTOREACTIVE CD4+T CELLS AND THEIR TCR REPERTOIRE IN PR3-ANCA ASSOCIATED VASCULITIS

ANNALS OF THE RHEUMATIC DISEASES, 2021, Vol.80, p.1

2021

Volltextzugriff (PDF)

VENOUS THROMBOEMBOLISM (VTE) IN PATIENTS WITH ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY (ANCA)-ASSOCIATED VASCULITIS - UNDERLYING PROTHROMBOTIC CONDITION IN ACTIVE DISEASE?

RHEUMATOLOGY, 2017, Vol.56, p.148

2017

Volltextzugriff (PDF)

Venous thromboembolism (VTE) in patients with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) - underlying prothrombotic condition in active disease?

THROMBOSIS RESEARCH, 2017, Vol.151, p.S119

2017

Volltextzugriff (PDF)

1 – 25 von 92

Suche als RSS-Feed

Aktive Filter

PublikationsformArtikel

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(83)
Mit Volltextzugriff
(81)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Historický Casopis
(1)
Läkartidningen
(1)

Neu hinzugefügt

... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Efficacy and safety of glecaprevir/pibrentasvir in renally-impaired patients with chronic hepatitis C virus genotype 1–6 infection

Late-onset neutropaenia in ANCA-associated vasculitis after rituximab treatment

LONG-TERM KIDNEY FUNCTION OUTCOME AFTER COVID-19 ASSOCIATED ACUTE KIDNEY INJURY AND KIDNEY REPLACEMENT THERAPY IN INTENSIVE CARE

Change in Albuminuria in Patients with ANCA-Associated Vasculitis Treated with Avacopan

CHANGE IN ALBUMINURIA IN PATIENTS WITH ANCA-ASSOCIATED VASCULITIS TREATED WITH AVACOPAN

Remission, Glucocorticoid Toxicity, Health-Related Quality of Life, and Safety Outcomes in Patients with Renal Involvement in the Phase 3 Trial of Avacopan for the Treatment of ANCA-Associated Vasculitis

INCIDENT ACUTE KIDNEY INJURY AND THE RISK OF DEMENTIA: THE STOCKHOLM CREATININE MEASUREMENTS (SCREAM) PROJECT

MYELOPEROXIDASE (MPO) POSITIVE EXTRACELLULAR VESICLES (EVS) EXPRESSING COMPLEMENT SPLIT PRODUCTS IN ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY (ANCA)-ASSOCIATED VASCULITIS (AAV)

Renal Recovery for Patients With Baseline eGFR ≤20 in Avacopan ADVOCATE Trial

URINARY INTERLEUKIN (IL)-16 IN ANTI - NEUTROPHIL CYTOPLASMIC ANTIBODY (ANCA)- ASSOCIATED VASCULITIS WITH KIDNEY INVOLVEMENT

Acceleration in kidney function decline after COVID-19 infection: the Stockholm CREAtinine Measurements (SCREAM) project

Rituximab in adult-onset IgA vasculitis

OUTCOME FOLLOWING COVID-19 INFECTION IN ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY (ANCA)-ASSOCIATED VASCULITIS

RNA SEQUENCING OF MICRODISSECTED KIDNEY BIOPSIES FROM IGA NEPHROPATHY PATIENTS

COMPLEMENT FACTOR BB AND FACTOR C4D IN IGA NEPHROPATHY AND IGA VASCULITIS

First exposure to rituximab is associated to high rate of anti-drug antibodies in systemic lupus erythematosus but not in ANCA-associated vasculitis

Effect of Avacopan, a Selective C5a Receptor Inhibitor, on Kidney Function in Patients with ANCA-Associated Vasculitis

CHOLINESTERASE INHIBITORS AND KIDNEY FUNCTION DECLINE IN PATIENTS WITH ALZHEIMER'S DEMENTIA

ANALYSIS OF THE PLASMA PROTEOME PROVIDES MECHANISTIC INSIGHTS INTO THE PATHOPHYSIOLOGY OF ANCA-ASSOCIATED VASCULITIS

PENTRAXIN-3 PLASMA LEVELS AND GENE POLYMORPHISMS IN ANCA-ASSOCIATED VASCULITIS

Proteinase 3 reactive CD4+T cells and their TCR repertoire in ANCA associated vasculitis

ACUTE KIDNEY INJURY AND MORTALITY RISK IN OLDER ADULTS WITH AND WITHOUT COVID-19: DATA FROM GEROCOVID STUDY

AUTOREACTIVE CD4+T CELLS AND THEIR TCR REPERTOIRE IN PR3-ANCA ASSOCIATED VASCULITIS

VENOUS THROMBOEMBOLISM (VTE) IN PATIENTS WITH ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY (ANCA)-ASSOCIATED VASCULITIS - UNDERLYING PROTHROMBOTIC CONDITION IN ACTIVE DISEASE?

Venous thromboembolism (VTE) in patients with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) - underlying prothrombotic condition in active disease?

Aktive Filter

Suchergebnisse filtern